Shreyans Patel

Dr. Shreyans Patel


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 April 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SPShreyans Patel
Shreyans Patel
KDKartikeya Dave
Kartikeya Dave
MGMario Jorge Garcia
Mario Jorge Garcia
CGCarlos A Gongora
Carlos A Gongora
MTMark I. Travin
Mark I. Travin
LZLili Zhang
Lili Zhang
Immune checkpoint inhibitors (ICIs) have dramatically changed the landscape of cancer treatment and are increasingly used either as monotherapy or in combination with other ICIs, chemotherapy, and molecularly targeted agents. ICI myocarditis is a rare but potentially fatal irAE associated with the use of ICI characterized by T-cell mediated cardiomyocyte death. Diagnosing ICI myocarditis can be intricate as its atypical presentations. Multimodal imaging plays a crucial role in the diagnosis and risk stratification of ICI myocarditis. Current management strategies for ICI myocarditis include corticosteroids and immunosuppressants. Multidisciplinary collaboration is vital in these cases—combining oncology expertise with cardiology insights.